
An Introduction to Asset Evaluation for Emerging Biotech Companies On-Demand Webinar
Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully transition investigational drugs from research to a commercially profitable product. These companies need to secure a combination of sophisticated investors, partners, and expert consultants to...